A cross-sectional study of psychosocial variables associated with medication burden among type 2 diabetes mellitus with multiple comorbidities in geriatric patients
DOI:
https://doi.org/10.15584/ejcem.2025.3.13Keywords:
geriatric patients, medication burden, multiple comorbidities, psychosocial variables, type 2 diabetes mellitusAbstract
Introduction and aim. As the population ages, the management of type 2 diabetes mellitus in older adults with multiple comorbidities becomes more complex. Geriatric patients often face a medication burden, impacting their quality of life and adherence. Psychosocial variables such as depression, anxiety, social support, and health literacy may influence how patients cope with their medications. This study explores the relationship between these variables and the burden in geriatric patients with type 2 diabetes and comorbidities, offering insight into improving care and outcomes.
Material and methods. The cross-sectional survey was carried out from April to September 2024. 250 patients were included. The demographics of the participants, the burden of the disease, polypharmacy, the burden of the medication, and the psychosocial variables were evaluated. Univariate and multivariate linear regression analyzes assessed the variables associated with the burden of medications.
Results. There was a positive correlation between the belief in medication, depression, disease burden, number of medications, number of comorbidities, and medication burden (p<0.05). Knowledge about medications was not significantly correlated with the burden (p>0.05).
Conclusion. Low self-efficacy, depression, polypharmacy, high disease burden, and decreased medication satisfaction can all contribute to medication burden. Comprehending these factors helps identify patients with geriatric diabetes and enables personalized treatment to ease their burden.
Downloads
References
Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet. 2012;380:37-43. doi: 10.1016/S0140-6736(12)60240-2
Qato DM, Wilder J, Schumm LP, et al. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011. JAMA Intern Med. 2016;176:473-482. doi: 10.1001/jamainternmed.2015.8581
Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in the elderly. Expert Opin Drug Saf. 2014;13:57-65. doi: 10.1517/14740338.2013.827660
Chen C, Feng Z, Fu Q, et al. Predictors of polypharmacy among elderly patients in China: the role of decision involvement, depression, and taking Chinese medicine behavior. Front Pharmacol. 2021;12:745688. doi: 10.3389/fphar.2021.745688
Maidment ID, Lawson S, Wong G, et al. Medication management in older people: the MEMORABLE realist synthesis. Health Serv Delivery Res. 2020;8:1–128. doi: 10.3310/hsdr08260
Morin L, Johnell K, Laroche ML, et al. The epidemiology of polypharmacy in older adults: Register-based prospective cohort study. Clin Epidemiol. 2018;10:289-298. doi: 10.2147/CLEP.S153458
Troncoso-Mariño A, Roso-Llorach A, López-Jiménez T, et al. Medication-related problems in older people with multimorbidity in Catalonia: a real world data study with 5 years’ follow-up. J Clin Med. 2021;10:709. doi: 10.3390/jcm10040709
Gallacher K, Jani B, Morrison D, et al. Qualitative systematic reviews of treatment burden in Stroke, Heart Failure and Diabetes - methodological challenges and solutions. BMC Med Res Methodol. 2013;13:10. doi: 10.1186/1471-2288-13-10
Katusiime B, Corlett S, Reeve J, et al. Measuring medicine-related experiences from the patient perspective: a systematic review. Patient Relat Outcome Meas. 2016;7:157-171. doi: 10.2147/prom.s102198
Awad A, Alhadab A, Albassam A. Medication-related burden and medication adherence among geriatric patients in Kuwait: a cross-sectional study. Front Pharmacol. 2020;11:1296. doi: 10.3389/fphar.2020.01296
Maddigan SL, Farris KB, Keating N, et al. Predictors of older adults’ capacity for medication management in a self-medication program: a retrospective chart review. J Aging Health. 2003;15:332-352. doi: 10.1177/0898264303251893
Bailey SC, Oramasionwu CU, Wolf MS. Rethinking adherence: a health literacy-informed model of medication self-management. J Health Commun. 2013;18:20-30. doi: 10.1080/10810730.2013.825672
Rosbach M, Andersen JS. Patient-experienced burden of treatment in patients with multimorbidity - a systematic review of qualitative data. PLoS ONE. 2017;12:e0179916. doi: 10.1371/journal.pone.0179916
Koetsenruijter J, van Eikelenboom N, van Lieshout J, et al. Social support and self-management capabilities in Diabetes patients: an international observational study. Patient Educ Couns. 2016;99:638-643. doi: 10.1016/j.pec.2015.10.029
Atkinson MJ, Kumar R, Cappelleri JC, et al. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM Version II) among outpatient pharmacy consumers. Value in Health. 2005;8:9-24. doi: 10.1111/j.1524-4733.2005.00066.x
Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value in Health. 2004;7:204-215. doi: 10.1111/j.1524-4733.2004.72252.x
Nicosia FM, Spar MJ, Stebbins M, et al. What is a medication-related problem? A qualitative study of older adults and primary care clinicians. J Gen Intern Med. 2020;35:724-731. doi: 10.1007/s11606-019-05463-z
Mohammed MA, Moles RJ, Chen TF. Medication-related burden and patients’ lived experience with medicine: a systematic review and metasynthesis of qualitative studies. BMJ Open. 2016;6:e010035. doi: 10.1136/bmjopen-2015-010035
Foley L, Hynes L, Murphy AW, et al. Just keep taking them, keep hoping they’ll work’: a qualitative study of adhering to medications for multimorbidity. Br J Health Psychol. 2022;27:691-715. doi: 10.1111/bjhp.12568
Chen WS, Islam MR, Ambepitiya S, et al. Factors associated with patient experiences of the burden of using medicines and health-related quality of life: a cross-sectional study. PLoS ONE. 2022;17:e0267593. doi: 10.1371/journal.pone.0267593
Zidan A, Awisu A, El-Hajj MS, et al. Medication-related burden among patients with chronic Disease conditions: perspectives of patients attending non-communicable Disease clinics in a primary healthcare setting in Qatar. Pharmacy. 2018;6:85. doi: 10.3390/pharmacy6030085
Dobler CC, Harb N, Maguire CA, et al. Treatment burden should be included in clinical practice guidelines. BMJ. 2018;363:k4065. doi: 10.1136/bmj.k4065
Herzig L, Zeller A, Pasquier J, et al. Factors associated with patients’ and GPs’ assessment of the burden of treatment in multimorbid patients: a cross-sectional study in primary care. BMC Fam Pract. 2019;20:88. doi: 10.1186/s12875-019-0974-z
Mostafavi F, Alavijeh FZ, Salahshouri A, et al. The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study. BioPsychoSocial Med. 2022;15: 1. doi: 10.1186/s13030-020-00202-x
Gonzalez JS, Tanenbaum ML, Commissariat PV. Psychosocial factors in medication adherence and diabetes self-management: Implications for research and practice. American Psychologist. 2016;71(7):539-551. doi: 10.1037/a0040388
Remelli F, Ceresini MG, Trevisan C, Noale M, Volpato S. Prevalence and impact of polypharmacy in older patients with type 2 diabetes. Aging Clin Exp Res. 2022;34(9):1969- 1983. doi: 10.1007/s40520-022-02165-1
Bekalu AF, Yenit MK, Tekile MT, Birarra MK. Medication-related burden and associated factors among diabetes mellitus patients at Felege Hiwot Comprehensive Specialized Hospital in northwest Ethiopia. Front Clin Diabetes Healthc. 2022:3:977216. doi: 10.3389/fcdhc.2022.977216
Yang C, Hui Z, Zeng D, et al. Examining and adapting the information- motivation-behavioural skills model of medication adherence among community-dwelling older patients with multimorbidity: protocol for a cross-sectional study. BMJ Open. 2020;10:e033431. doi: 10.1136/bmjopen-2019-033431
Yang C, Lee DTF, Chair SY. Validation and adaption of an information-motivation-behavioral skills model of medication adherence in older patients with multimorbidity. Patient Educ Couns. 2023;113:107756. doi: 10.1016/j.pec.2023.107756
Borson S, Scanlan J, Brush M, et al. The Mini-cog: a cognitive ‘vital signs’ measure for Dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000;15:1021-107. doi: 10.1002/1099-1166(200011)15:11<1021::A-ID GPS234>3.0.CO;2-6
Okere AN, Renier CM, Morse J. Development and validation of a survey to assess patient-perceived medication knowledge and confidence in medication use. J Nurs Meas. 2014;22:120-134. doi: 10.1891/1061-3749.22.1.120
Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1-24. doi: 10.1080/08870449908407311
Rayana D, Lyubomir M, Miglena D, Maria K. Medication adherence among patients with diabetes mellitus and its related factors - A real-world pilot study in Bulgaria. Medicina, 2023;59(7):1205. doi: 10.3390/medicina59071205
Lalwani RK, Shah JD, Chatterjea T, Nadakuduru PR, Erande S. Prevalence of depression in Indian patients with type 2 diabetes mellitus and/or hypertension: DEPTH Study. Eur J Clin Exp Med. 2019;17(4):315-325. doi: 10.15584/ejcem.2019.4.5
Zhao Y, Atun R, Oldenburg B, et al. Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data. Lancet Glob Health. 2020;8:840-849. doi: 10.1016/S2214-109X(20)30127-3
Hajar B, Hassan B, Eddine OD, et al. The influence of therapeutic education on diabetes-related distress and therapeutic adherence among patients with type 2 diabetes in Tetouan, Morocco. Eur J Clin Exp Med. 2024;22(1):140-146. doi:10.15584/ejcem.2024.1.28
Asti AD, Sarwono, Kinwati, Suwaryo PAW. Assessment of the quality of life in type 2 diabetes patients - a comparative study of WHOQOL- -BREF and DQOL instruments. Eur J Clin Exp Med. 2024;22(4):826-832. doi: 10.15584/ejcem.2024.4.21 Deborah YH, Mary DG, Felicia HB, Jeffrey SG, Korey H, Mark P. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care. 2021;39(12):2126-2140. doi: 10.2337/dc16-2053
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
